Nektar Therapeutics
IMMUNOTHERAPEUTIC COMBINATION FOR TREATING CANCER

Abstract:

Provided herein are methods and compositions for treating a subject having cancer by administering to the subject a neoantigen-based vaccine composition and a long acting, IL-2RP.beta.-selective agonist composition comprised of compounds of Formula (I), and optionally, an anti-PD-1 antibody.